Streamlined Treatment of Pulmonary Exacerbations in Pediatrics (NCT06654752)

🧪 Interventions in This Study

• Immediate Oral Antibiotics (OTHER)
• Tailored Treatment: Oral Antibiotics only if Additional Treatment needed (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (33 Sites)

Showing the first 25 of 33 sites.

• The Children's Hospital Alabama & University of Alabama at Birmingham — Birmingham, Alabama
• Tucson Cystic Fibrosis Center — Tucson, Arizona
• Children's Hospital of Los Angeles & Anton Yelchin Cystic Fibrosis Clinic — Los Angeles, California
• Stanford University — Palo Alto, California
• Rady Children's Hospital at University of California San Diego — San Diego, California
• Children's Hospital of Colorado — Aurora, Colorado
• Children's Healthcare of Atlanta & Emory University — Atlanta, Georgia
• Ann & Robert H. Lurie Children's Hospital of Chicago & Northwestern University — Chicago, Illinois
• Riley Hospital for Children & Indiana University — Indianapolis, Indiana
• University of Iowa — Iowa City, Iowa
• Johns Hopkins Hospital, Johns Hopkins University — Baltimore, Maryland
• Boston Children's Hospital & Harvard University — Boston, Massachusetts
• University of Michigan Health System — Ann Arbor, Michigan
• Children's Hospitals and Clinics of Minnesota — Minneapolis, Minnesota
• The Minnesota Cystic Fibrosis Center & University of Minnesota — Minneapolis, Minnesota
• Children's Mercy Hospital — Kansas City, Missouri
• St. Louis Children's Hospital & Washington University School of Medicine — St Louis, Missouri
• University of Rochester Medical Center Strong Memorial — Rochester, New York
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
• Oregon Health & Science University — Portland, Oregon
• Children's Hospital of Philadelphia & University of Pennsylvania — Philadelphia, Pennsylvania
• Children's Hospital of Pittsburgh of UPMC & University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
• Medical University of South Carolina — Charleston, South Carolina
• University of Texas Southwestern & Children's Health — Dallas, Texas

📞 Contact the Study Coordinator

Phone: (206) 897-1922

Email: eenright@uw.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cystic Fibrosis

• Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease — Chapel Hill, North Carolina
• Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age — Orange, California
• Hyperpolarized Imaging for New Treatments — Cincinnati, Ohio
• Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI — Cincinnati, Ohio
• Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older — Nedlands,
• Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis — Cincinnati, Ohio

Explore by condition: All Cystic Fibrosis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.